{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T20:39:22Z","timestamp":1779223162405,"version":"3.51.4"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Mol Morphol"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s00795-022-00312-1","type":"journal-article","created":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T13:03:08Z","timestamp":1643720588000},"page":"110-122","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The role of mineralocorticoids and glucocorticoids under the impact of 11\u03b2-hydroxysteroid dehydrogenase in human breast lesions"],"prefix":"10.1007","volume":"55","author":[{"given":"Mingzhen","family":"Cai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keely","family":"McNamara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuto","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narumi","family":"Harada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minoru","family":"Miyashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Tada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takanori","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hironobu","family":"Sasano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,2,1]]},"reference":[{"key":"312_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394\u2013424","journal-title":"CA Cancer J Clin"},{"key":"312_CR2","unstructured":"WHO classification of tumours editorial board (2019) Breast tumours. WHO classification of tumours, 5th ed, vol 2. International Agency for Research on Cancer, Lyon"},{"key":"312_CR3","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1002\/path.2808","volume":"223","author":"A Bombonati","year":"2011","unstructured":"Bombonati A, Sgroi DC (2011) The molecular pathology of breast cancer progression. J Pathol 223:308\u2013318","journal-title":"J Pathol"},{"key":"312_CR4","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.path.2017.09.007","volume":"11","author":"LC Collins","year":"2018","unstructured":"Collins LC (2018) Precursor lesions of the low-grade breast neoplasia pathway. S Surg Pathol Clin 11:177\u2013197","journal-title":"S Surg Pathol Clin"},{"key":"312_CR5","doi-asserted-by":"publisher","first-page":"955","DOI":"10.4161\/cbt.10.10.13879","volume":"10","author":"GK Malhotra","year":"2010","unstructured":"Malhotra GK, Zhao X, Band H, Band V (2010) Histological, molecular and functional subtypes of breast cancers. Cancer Biol Ther 10:955\u2013960","journal-title":"Cancer Biol Ther"},{"key":"312_CR6","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.mpdhp.2011.12.004","volume":"18","author":"EA Rakha","year":"2012","unstructured":"Rakha EA (2012) The low nuclear grade breast neoplasia family. Diagn Histopathol 18:124\u2013132","journal-title":"Diagn Histopathol"},{"key":"312_CR7","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1093\/ajcp\/aqz012","volume":"152","author":"AM Gordian-Arroyo","year":"2019","unstructured":"Gordian-Arroyo AM, Zynger DL, Tozbikian GH (2019) Impact of the 2018 ASCO\/CAP HER2 guideline focused update. Am J Clin Pathol 152:17\u201326","journal-title":"Am J Clin Pathol"},{"key":"312_CR8","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1001\/jama.295.21.2492","volume":"295","author":"LA Carey","year":"2006","unstructured":"Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K, Karaca G, Troester MA, Tse CK, Edmiston S (2006) Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 295:2492\u20132502","journal-title":"JAMA"},{"key":"312_CR9","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/35021093","volume":"406","author":"CM Perou","year":"2000","unstructured":"Perou CM, S\u00f8rlie T, Eisen MB, Van De Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA (2000) Molecular portraits of human breast tumours. Nature 406:747\u2013752","journal-title":"Nature"},{"key":"312_CR10","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1093\/annonc\/mdu493","volume":"26","author":"Z Sun","year":"2015","unstructured":"Sun Z, Prat A, Cheang MC, Gelber RD, Perou CM (2015) Chemotherapy benefit for \u2018ER-positive\u2019breast cancer and contamination of Nonluminal subtypes\u2014waiting for TAILORx and RxPONDER. Ann Oncol 26:70\u201374","journal-title":"Ann Oncol"},{"key":"312_CR11","doi-asserted-by":"publisher","first-page":"806","DOI":"10.5858\/arpa.2015-0133-RA","volume":"140","author":"P Tang","year":"2016","unstructured":"Tang P, Tse GM (2016) Immunohistochemical surrogates for molecular classification of breast carcinoma: a 2015 update. Arch Pathol Lab Med 140:806\u2013814","journal-title":"Arch Pathol Lab Med"},{"key":"312_CR12","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1023\/A:1022896515287","volume":"7","author":"OT Oftedal","year":"2002","unstructured":"Oftedal OT (2002) The mammary gland and its origin during synapsid evolution. J Mamm Gland Biol Neoplasia 7:225\u2013252","journal-title":"J Mamm Gland Biol Neoplasia"},{"key":"312_CR13","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12967-020-02248-5","volume":"18","author":"T Weng","year":"2020","unstructured":"Weng T, Wu P, Zhang W, Zheng Y, Li Q, Jin R, Chen H, You C, Guo S, Han C, Wang X (2020) Regeneration of skin appendages and nerves: current status and further challenges. J Transl Med 18:53","journal-title":"J Transl Med"},{"key":"312_CR14","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.semcdb.2007.02.005","volume":"18","author":"RB Widelitz","year":"2007","unstructured":"Widelitz RB, Veltmaat JM, Mayer JA, Foley J, Chuong C-M (2007) Mammary glands and feathers: comparing two skin appendages which help define novel classes during vertebrate evolution. Semin Cell Dev Biol 18:255\u2013266","journal-title":"Semin Cell Dev Biol"},{"key":"312_CR15","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1007\/978-0-306-48113-0_250","volume-title":"Encyclopedia of women\u2019s health","author":"KL Ashby","year":"2004","unstructured":"Ashby KL (2004) Mammary glands. Encyclopedia of women\u2019s health. Springer, Boston, pp 748\u2013750"},{"issue":"2","key":"312_CR16","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1677\/joe.0.1320305","volume":"132","author":"H Sasano","year":"1992","unstructured":"Sasano H, Fukushima K, Sasaki I, Matsuno S, Nagura H, Krozowski ZS (1992) Immunolocalization of mineralocorticoid receptor in human kidney, pancreas, salivary, mammary and sweat glands: a light and electron microscopic immunohistochemical study. J Endocrinol 132(2):305\u2013310","journal-title":"J Endocrinol"},{"key":"312_CR17","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.2147\/CCID.S224211","volume":"13","author":"E Niculet","year":"2020","unstructured":"Niculet E, Bobeica C, Tatu AL (2020) Glucocorticoid-induced skin atrophy: the old and the new. Clin Cosmet Investig Dermatol 13:1041\u20131050","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"312_CR18","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1210\/me.2007-0421","volume":"22","author":"SD Conzen","year":"2008","unstructured":"Conzen SD (2008) Minireview: nuclear receptors and breast cancer. Mol Endocrinol 22:2215\u20132228","journal-title":"Mol Endocrinol"},{"key":"312_CR19","doi-asserted-by":"publisher","first-page":"3593","DOI":"10.2174\/138161210793797906","volume":"16","author":"JS Vaidya","year":"2010","unstructured":"Vaidya JS, Baldassarre G, Thorat MA, Massarut S (2010) Role of glucocorticoids in breast cancer. Curr Pharm Des 16:3593\u20133600","journal-title":"Curr Pharm Des"},{"key":"312_CR20","first-page":"1334","volume":"79","author":"S Kenouch","year":"1994","unstructured":"Kenouch S, Lombes M, Delahaye F, Eugene E, Bonvalet JP, Farman N (1994) Human skin as target for aldosterone: coexpression of mineralocorticoid receptors and 11 beta-hydroxysteroid dehydrogenase. J Clin Endocrinol Metab 79:1334\u20131341","journal-title":"J Clin Endocrinol Metab"},{"key":"312_CR21","doi-asserted-by":"publisher","first-page":"R11","DOI":"10.1016\/0303-7207(94)90176-7","volume":"105","author":"AL Albiston","year":"1994","unstructured":"Albiston AL, Obeyesekere VR, Smith RE, Krozowski ZS (1994) Cloning and tissue distribution of the human 1 l\u03b2-hydroxysteroid dehydrogenase type 2 enzyme. Mol Cell Endocrinol 105:R11\u2013R17","journal-title":"Mol Cell Endocrinol"},{"key":"312_CR22","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S0083-6729(08)60646-9","volume":"57","author":"PM Stewart","year":"1999","unstructured":"Stewart PM, Krozowski ZS (1999) 11 beta-hydroxysteroid dehydrogenase. Vitam Horm 57:249\u2013324","journal-title":"Vitam Horm"},{"key":"312_CR23","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.placenta.2015.11.009","volume":"37","author":"K Heussner","year":"2016","unstructured":"Heussner K, Ruebner M, Huebner H, Rascher W, Menendez-Castro C, Hartner A, Fahlbusch FB, Rauh M (2016) Species differences of 11beta-hydroxysteroid dehydrogenase type 2 function in human and rat term placenta determined via LC-MS\/MS. Placenta 37:79\u201384","journal-title":"Placenta"},{"key":"312_CR24","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1126\/science.3037703","volume":"237","author":"JL Arriza","year":"1987","unstructured":"Arriza JL, Weinberger C, Cerelli G, Glaser TM, Handelin BL, Housman DE, Evans RM (1987) Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor. Science 237:268\u2013275","journal-title":"Science"},{"key":"312_CR25","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1002\/cphy.c130044","volume":"4","author":"E Gomez-Sanchez","year":"2014","unstructured":"Gomez-Sanchez E, Gomez-Sanchez CE (2014) The multifaceted mineralocorticoid receptor. Compr Physiol 4:965\u2013994","journal-title":"Compr Physiol"},{"key":"312_CR26","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1128\/MCB.01190-09","volume":"30","author":"MD Galigniana","year":"2010","unstructured":"Galigniana MD, Erlejman AG, Monte M, Gomez-Sanchez C, Piwien-Pilipuk G (2010) The hsp90-FKBP52 complex links the mineralocorticoid receptor to motor proteins and persists bound to the receptor in early nuclear events. Mol Cell Biol 30:1285\u20131298","journal-title":"Mol Cell Biol"},{"key":"312_CR27","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1210\/mend.15.7.0659","volume":"15","author":"M Nishi","year":"2001","unstructured":"Nishi M, Ogawa H, Ito T, Matsuda K-I, Kawata M (2001) Dynamic changes in subcellular localization of mineralocorticoid receptor in living cells: in comparison with glucocorticoid receptor using dual-color labeling with green fluorescent protein spectral variants. Mol Endocrinol 15:1077\u20131092","journal-title":"Mol Endocrinol"},{"key":"312_CR28","doi-asserted-by":"publisher","first-page":"5879","DOI":"10.21873\/anticanres.13792","volume":"39","author":"J\u00c4\u00c4Skel\u00c4Inen A, Jukkola A, Haapasaa","year":"2019","unstructured":"J\u00c4\u00c4Skel\u00c4Inen A, Jukkola A, Haapasaari K-M, Auvinen P, Soini Y, Karihtala P, (2019) Cytoplasmic mineralocorticoid receptor expression predicts dismal local relapse-free survival in non-triple-negative breast cancer. Anticancer Res 39:5879\u20135890","journal-title":"Anticancer Res"},{"key":"312_CR29","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1161\/CIRCRESAHA.120.317424","volume":"127","author":"A Lother","year":"2020","unstructured":"Lother A (2020) Mineralocorticoid receptors. Circ Res 127:354\u2013356","journal-title":"Circ Res"},{"issue":"Suppl 1","key":"312_CR30","doi-asserted-by":"publisher","first-page":"OR12-02","DOI":"10.1210\/jendso\/bvaa046.502","volume":"4","author":"MG Petrillo","year":"2020","unstructured":"Petrillo MG, Jewell CM, Oakley RH, Cidlowski JA (2020) OR12-02 When the glucocorticoid receptor meets the mineralocorticoid receptor in the nucleus of human cells. J Endocr Soc 4(Suppl 1):OR12-02","journal-title":"J Endocr Soc"},{"key":"312_CR31","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1210\/me.2002-0103","volume":"16","author":"M Kingsley-Kallesen","year":"2002","unstructured":"Kingsley-Kallesen M, Mukhopadhyay SS, Wyszomierski SL, Schanler S, Gn S, Rosen JM (2002) The mineralocorticoid receptor may compensate for the loss of the glucocorticoid receptor at specific stages of mammary gland development. Mol Endocrinol 16:2008\u20132018","journal-title":"Mol Endocrinol"},{"key":"312_CR32","first-page":"2001","volume":"17","author":"H Sasano","year":"1997","unstructured":"Sasano H, Frost AR, Saitoh R, Matsunaga G, Nagura H, Krozowski ZS, Silverberg SG (1997) Localization of mineralocorticoid receptor and 11 beta-hydroxysteroid dehydrogenase type II in human breast and its disorders. Anticancer Res 17:2001\u20132007","journal-title":"Anticancer Res"},{"key":"312_CR33","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1111\/j.1349-7006.2010.01673.x","volume":"101","author":"Y Sasaki","year":"2010","unstructured":"Sasaki Y, Miki Y, Hirakawa H, Onodera Y, Takagi K, Ji A, Honma S, Ishida T, Watanabe M, Sasano H (2010) Immunolocalization of estrogen-producing and metabolizing enzymes in benign breast disease: comparison with normal breast and breast carcinoma. Cancer Sci 101:2286\u20132292","journal-title":"Cancer Sci"},{"key":"312_CR34","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1210\/endrev\/bnz001","volume":"41","author":"B Trabert","year":"2020","unstructured":"Trabert B, Sherman ME, Kannan N, Stanczyk FZ (2020) Progesterone and breast cancer. Endocr Rev 41:320\u2013344","journal-title":"Endocr Rev"},{"key":"312_CR35","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1186\/1471-2407-11-292","volume":"11","author":"Y Su","year":"2011","unstructured":"Su Y, Zheng Y, Zheng W, Gu K, Chen Z, Li G, Cai Q, Lu W, Shu XO (2011) Distinct distribution and prognostic significance of molecular subtypes of breast cancer in Chinese women: a population-based cohort study. BMC Cancer 11:292","journal-title":"BMC Cancer"},{"key":"312_CR36","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1111\/j.1440-1827.2009.02444.x","volume":"59","author":"H Sasano","year":"2009","unstructured":"Sasano H, Miki Y, Nagasaki S, Suzuki T (2009) In situ estrogen production and its regulation in human breast carcinoma: from endocrinology to intracrinology. Pathol Int 59:777\u2013789","journal-title":"Pathol Int"},{"key":"312_CR37","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s10549-020-05523-7","volume":"180","author":"A Kanai","year":"2020","unstructured":"Kanai A, McNamara KM, Iwabuchi E, Miki Y, Onodera Y, Guestini F, Khalid F, Sagara Y, Ohi Y, Rai Y, Yamaguchi R, Tanaka M, Miyashita M, Ishida T, Sasano H (2020) Significance of glucocorticoid signaling in triple-negative breast cancer patients: a newly revealed interaction with androgen signaling. Breast Cancer Res Treat 180:97\u2013110","journal-title":"Breast Cancer Res Treat"},{"key":"312_CR38","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/s41416-020-0837-3","volume":"123","author":"R Saito","year":"2020","unstructured":"Saito R, Miki Y, Abe T, Miyauchi E, Abe J, Nanamiya R, Inoue C, Sato I, Sasano H (2020) 11\u03b2 hydroxysteroid dehydrogenase 1: a new marker for predicting response to immune-checkpoint blockade therapy in non-small-cell lung carcinoma. Br J Cancer 123:61\u201371","journal-title":"Br J Cancer"},{"key":"312_CR39","doi-asserted-by":"publisher","first-page":"9823","DOI":"10.1038\/s41598-018-28223-1","volume":"8","author":"D Ogias","year":"2018","unstructured":"Ogias D, Rattes IC, Hosoya LYM, Zulian JG, Yan CYI, Gama P (2018) Neonatal- maternal separation primes zymogenic cells in the rat gastric mucosa through glucocorticoid receptor activity. Sci Rep 8:9823","journal-title":"Sci Rep"},{"key":"312_CR40","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s00428-017-2258-0","volume":"472","author":"G Kl\u00f6ppel","year":"2018","unstructured":"Kl\u00f6ppel G, La Rosa S (2018) Ki67 labeling index: assessment and prognostic role in gastroenteropancreatic neuroendocrine neoplasms. Virchows Arch 472:341\u2013349","journal-title":"Virchows Arch"},{"key":"312_CR41","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/modpathol.2014.156","volume":"28","author":"MD Reid","year":"2015","unstructured":"Reid MD, Bagci P, Ohike N, Saka B, Seven IE, Dursun N, Balci S, Gucer H, Jang K-T, Tajiri T (2015) Calculation of the Ki67 index in pancreatic neuroendocrine tumors: a comparative analysis of four counting methodologies. Mod Pathol 28:686\u2013694","journal-title":"Mod Pathol"},{"key":"312_CR42","doi-asserted-by":"publisher","first-page":"S52","DOI":"10.1038\/modpathol.2010.55","volume":"23","author":"DC Allred","year":"2010","unstructured":"Allred DC (2010) Issues and updates: evaluating estrogen receptor-\u03b1, progesterone receptor, and HER2 in breast cancer. Mod Pathol 23:S52\u2013S59","journal-title":"Mod Pathol"},{"key":"312_CR43","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.1096\/fj.09-147926","volume":"24","author":"AND Cat","year":"2010","unstructured":"Cat AND, Griol-Charhbili V, Loufrani L, Labat C, Benjamin L, Farman N, Lacolley P, Henrion D, Jaisser F (2010) The endothelial mineralocorticoid receptor regulates vasoconstrictor tone and blood pressure. FASEB J 24:2454\u20132463","journal-title":"FASEB J"},{"key":"312_CR44","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1177\/39.6.1709656","volume":"39","author":"S-R Shi","year":"1991","unstructured":"Shi S-R, Key ME, Kalra KL (1991) Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 39:741\u2013748","journal-title":"J Histochem Cytochem"},{"key":"312_CR45","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.mce.2014.10.008","volume":"408","author":"S Konosu-Fukaya","year":"2015","unstructured":"Konosu-Fukaya S, Nakamura Y, Satoh F, Felizola SJA, Maekawa T, Ono Y, Morimoto R, Ise K, Takeda K-I, Katsu K, Fujishima F, Kasajima A, Watanabe M, Arai Y, Gomez-Sanchez EP, Gomez-Sanchez CE, Doi M, Okamura H, Sasano H (2015) 3\u03b2-Hydroxysteroid dehydrogenase isoforms in human aldosterone-producing adenoma. Mol Cell Endocrinol 408:205\u2013212","journal-title":"Mol Cell Endocrinol"},{"key":"312_CR46","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1002\/hep.27940","volume":"62","author":"H Nie","year":"2015","unstructured":"Nie H, Li J, Yang XM, Cao QZ, Feng MX, Xue F, Wei L, Qin W, Gu J, Xia Q (2015) Mineralocorticoid receptor suppresses cancer progression and the Warburg effect by modulating the miR-338-3p-PKLR axis in hepatocellular carcinoma. Hepatology 62:1145\u20131159","journal-title":"Hepatology"},{"key":"312_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1677\/joe.1.06017","volume":"186","author":"JM Connell","year":"2005","unstructured":"Connell JM, Davies E (2005) The new biology of aldosterone. J Endocrinol 186:1\u201320","journal-title":"J Endocrinol"},{"key":"312_CR48","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1002\/mc.22643","volume":"56","author":"N Queisser","year":"2017","unstructured":"Queisser N, Schupp N, Schwarz E, Hartmann C, Mackenzie GG, Oteiza PI (2017) Aldosterone activates the oncogenic signals ERK1\/2 and STAT3 via redox-regulated mechanisms. Mol Carcinog 56:1868\u20131883","journal-title":"Mol Carcinog"},{"key":"312_CR49","doi-asserted-by":"publisher","first-page":"94","DOI":"10.18632\/oncotarget.6475","volume":"7","author":"DC Rigiracciolo","year":"2016","unstructured":"Rigiracciolo DC, Scarpelli A, Lappano R, Pisano A, Santolla MF, Avino S, De Marco P, Bussolati B, Maggiolini M, De Francesco EM (2016) GPER is involved in the stimulatory effects of aldosterone in breast cancer cells and breast tumor-derived endothelial cells. Oncotarget 7:94\u2013111","journal-title":"Oncotarget"},{"key":"312_CR50","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.mce.2010.09.014","volume":"332","author":"JB Pippal","year":"2011","unstructured":"Pippal JB, Cheung CMI, Yao Y-Z, Brennan FE, Fuller PJ (2011) Characterization of the zebrafish (Danio rerio) mineralocorticoid receptor. Mol Cell Endocrinol 332:58\u201366","journal-title":"Mol Cell Endocrinol"},{"key":"312_CR51","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1210\/en.2004-0128","volume":"146","author":"A Sturm","year":"2005","unstructured":"Sturm A, Bury N, Dengreville L, Fagart J, Flouriot G, Rafestin-Oblin ME, Prunet P (2005) 11-deoxycorticosterone is a potent agonist of the rainbow trout (Oncorhynchus mykiss) mineralocorticoid receptor. Endocrinology 146:47\u201355","journal-title":"Endocrinology"},{"key":"312_CR52","doi-asserted-by":"publisher","first-page":"3655","DOI":"10.1042\/BCJ20160579","volume":"473","author":"A Sugimoto","year":"2016","unstructured":"Sugimoto A, Oka K, Sato R, Adachi S, Baker ME, Katsu Y (2016) Corticosteroid and progesterone transactivation of mineralocorticoid receptors from Amur sturgeon and tropical gar. Biochem J 473:3655\u20133665","journal-title":"Biochem J"},{"key":"312_CR53","doi-asserted-by":"publisher","first-page":"eaar2668","DOI":"10.1126\/scisignal.aar2668","volume":"12","author":"Y Katsu","year":"2019","unstructured":"Katsu Y, Kohno S, Oka K, Lin X, Otake S, Pillai NE, Takagi W, Hyodo S, Venkatesh B, Baker ME (2019) Transcriptional activation of elephant shark mineralocorticoid receptor by corticosteroids, progesterone, and spironolactone. Sci Signal 12:eaar2668","journal-title":"Sci Signal"},{"key":"312_CR54","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1210\/endo-102-6-1686","volume":"102","author":"G Wambach","year":"1978","unstructured":"Wambach G, Higgins JR (1978) Antimineralocorticoid action of progesterone in the rat: correlation of the effect on electrolyte excretion and interaction with renal mineralocorticoid receptors. Endocrinology 102:1686\u20131693","journal-title":"Endocrinology"},{"key":"312_CR55","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1210\/jcem-18-11-1237","volume":"18","author":"RL Landau","year":"1958","unstructured":"Landau RL, Lugibihl K (1958) Inhibition of the sodium-retaining influence of aldosterone by progesterone. J Clin Endocrinol Metab 18:1237\u20131245","journal-title":"J Clin Endocrinol Metab"},{"key":"312_CR56","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1172\/JCI105359","volume":"45","author":"GW Sharp","year":"1966","unstructured":"Sharp GW, Komack CL, Leaf A (1966) Studies on the binding of aldosterone in the toad bladder. J Clin Invest 45:450\u2013459","journal-title":"J Clin Invest"},{"key":"312_CR57","doi-asserted-by":"publisher","first-page":"eaao1520","DOI":"10.1126\/scisignal.aao1520","volume":"11","author":"Y Katsu","year":"2018","unstructured":"Katsu Y, Oka K, Baker ME (2018) Evolution of human, chicken, alligator, frog, and zebrafish mineralocorticoid receptors: allosteric influence on steroid specificity. Sci Signal 11:eaao1520","journal-title":"Sci Signal"},{"key":"312_CR58","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1161\/HYPERTENSIONAHA.119.12802","volume":"74","author":"JL Faulkner","year":"2019","unstructured":"Faulkner JL, Kennard S, Huby A-C, Antonova G, Lu Q, Jaffe IZ, Patel VS, Fulton DJR, Belin de Chantem\u00e8le EJ (2019) Progesterone predisposes females to obesity-associated leptin-mediated endothelial dysfunction via upregulating endothelial MR (mineralocorticoid receptor) expression. Hypertension 74:678\u2013686","journal-title":"Hypertension"},{"key":"312_CR59","first-page":"1306","volume":"85","author":"G Hirasawa","year":"2000","unstructured":"Hirasawa G, Takeyama J, Sasano H, Fukushima K, Suzuki T, Muramatu Y, Darnel AD, Kaneko C, Hiwatashi N, Toyota T, Nagura H, Krozowski ZS (2000) 11Beta-hydroxysteroid dehydrogenase type II and mineralocorticoid receptor in human placenta. J Clin Endocrinol Metab 85:1306\u20131309","journal-title":"J Clin Endocrinol Metab"},{"key":"312_CR60","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1097\/PAS.0b013e31815f2362","volume":"32","author":"E Yakirevich","year":"2008","unstructured":"Yakirevich E, Morris DJ, Tavares R, Meitner PA, Lechpammer M, Noble L, de Rodriguez AF, Gomez-Sanchez CE, Wang LJ, Sabo E, DeLellis RA, Resnick MB (2008) Mineralocorticoid receptor and 11\u03b2-hydroxysteroid dehydrogenase type II expression in renal cell neoplasms: a tissue microarray and quantitative RT-PCR study. Am J Surg Pathol 32:874\u2013883","journal-title":"Am J Surg Pathol"}],"container-title":["Medical Molecular Morphology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00795-022-00312-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00795-022-00312-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00795-022-00312-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T15:14:39Z","timestamp":1653491679000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00795-022-00312-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,1]]},"references-count":60,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["312"],"URL":"https:\/\/doi.org\/10.1007\/s00795-022-00312-1","relation":{},"ISSN":["1860-1480","1860-1499"],"issn-type":[{"value":"1860-1480","type":"print"},{"value":"1860-1499","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,1]]},"assertion":[{"value":"25 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the authors have declared that no conflict of interest exists.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}